Stephanie Dunlap – Review of Guidelines Directed Medical Therapy of CHF
Salepage : Review of Guidelines Directed Medical Therapy of CHF
Archive : Review of Guidelines Directed Medical Therapy of CHF Digital Download
Delivery : Digital Download Immediately
In this session, the presenter defines systolic heart failure and discusses medications used for it. Additionally, the advantages of the newest medications are discussed.
Learning Objectives:
- Name meds used for systolic heart failure
- Describe the advantages of the newest med for heart failure
- Define Systolic Heart failure
Stephanie Dunlap, DO, Professor of Medicine, Medical Director, Advanced Heart Failure and Coronary Care Unit, Augusta University
Dr. Dunlap, a native of West Virginia attended West VWSOM. She did her internship and residency in Southern Florida, then traveled to NC where she completed her Cardiovascular Fellowship and two years of clinical heart failure research. She then completed a fellowship in heart transplantation and MC5 at the Cleveland Clinic. Since then, she has had academic appointments at Rush University, University of Illinois at Chicago, University of Cincinnati, and is now at Medical College of Georgia, Augusta University where she is Director of Advance Heart Failure and where she expects to launch an MC5/LVAD program July, 2021.
DISCLOSURE: Grants: Bayer Healthcare and NIH
More from Categories : Medical
Reviews
There are no reviews yet.